A first-in-human study of CD123 NK cell engager SAR443579 in relapsed or refractory acute myeloid leukemia, B-cell acute lymphoblastic leukemia, or high-risk myelodysplasia.Anthony S. Stein, Ashish Bajel, Sylvain Garciaz et al.|Journal of Clinical Oncology|2023Cited by 12